IYH vs. IBB
Compare and contrast key facts about iShares U.S. Healthcare ETF (IYH) and iShares Nasdaq Biotechnology ETF (IBB).
IYH and IBB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IYH is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Health Care Index. It was launched on Jun 12, 2000. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001. Both IYH and IBB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IYH or IBB.
Correlation
The correlation between IYH and IBB is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
IYH vs. IBB - Performance Comparison
Key characteristics
IYH:
0.39
IBB:
0.08
IYH:
0.61
IBB:
0.24
IYH:
1.08
IBB:
1.03
IYH:
0.36
IBB:
0.05
IYH:
1.23
IBB:
0.35
IYH:
3.54%
IBB:
4.37%
IYH:
11.08%
IBB:
17.91%
IYH:
-43.12%
IBB:
-62.85%
IYH:
-12.16%
IBB:
-24.17%
Returns By Period
In the year-to-date period, IYH achieves a 2.34% return, which is significantly higher than IBB's -2.33% return. Over the past 10 years, IYH has outperformed IBB with an annualized return of 8.35%, while IBB has yielded a comparatively lower 2.50% annualized return.
IYH
2.34%
-2.69%
-4.26%
3.63%
7.32%
8.35%
IBB
-2.33%
-0.50%
-1.35%
-0.08%
1.91%
2.50%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IYH vs. IBB - Expense Ratio Comparison
IYH has a 0.43% expense ratio, which is lower than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
IYH vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Healthcare ETF (IYH) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IYH vs. IBB - Dividend Comparison
IYH's dividend yield for the trailing twelve months is around 1.56%, more than IBB's 0.39% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IYH iShares U.S. Healthcare ETF | 1.26% | 1.18% | 1.10% | 0.94% | 1.16% | 1.14% | 1.95% | 1.10% | 1.29% | 2.02% | 1.05% | 1.12% |
IBB iShares Nasdaq Biotechnology ETF | 0.29% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
IYH vs. IBB - Drawdown Comparison
The maximum IYH drawdown since its inception was -43.12%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for IYH and IBB. For additional features, visit the drawdowns tool.
Volatility
IYH vs. IBB - Volatility Comparison
The current volatility for iShares U.S. Healthcare ETF (IYH) is 3.48%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 5.69%. This indicates that IYH experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.